Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Join Channel
Consolidated Standalone

Anuh Pharma

₹227.9 2.4 | 1.1%

Market Cap ₹1142 Cr.

Stock P/E 21.1

P/B 4.1

Current Price ₹227.9

Book Value ₹ 55

Face Value 5

52W High ₹265

Dividend Yield 0.88%

52W Low ₹ 86.1

Edit Ratio

Anuh Pharma Research see more...

Overview Inc. Year: 1960Industry: Pharmaceuticals & Drugs

Anuh Pharma Ltd is an India-based organisation engaged in the production of prescribed drugs, medicinal, chemical and botanical merchandise. The Company operates via Bulk drugs and Chemicals section. The Company manufactures active pharmaceutical components (APIs). It also sells bulk pills and chemical compounds. The Company's production operations are located at Tarapur in Maharashtra. The Company produces Macrolides, consisting of Ertythromycin Base and Ertythromycin Estolate; Higher Macrolides, together with Roxithromycin, Azithromycin and Clarithromycin; Quinolones, inclusive of Levofloxacin Hemihydrate and Ofloxacin; Chloramphenicol, inclusive of Chloramphenicol and Chloramphenicol Palmitate; anti-Tuberculosis (TB) Drug, such as Pyrazinamide, and corticosteroids, including Betamethasone Sodium Phosphate, Betamethasone Valerate, Betamethasone Dipropionate, Mometasone Furoate, Prednisolone Acetate, Betamethasone Acetate and Clobetasol Propionate.

Read More..

Anuh Pharma Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Anuh Pharma Quarterly Results

#(Fig in Cr.) Mar 2021 Jun 2021 Sep 2021 Dec 2021 Jun 2022 Sep 2022 Dec 2022 Jun 2023 Sep 2023 Dec 2023
Net Sales 97 117 109 132 116 115 139 161 150 172
Other Income 2 2 2 0 1 2 2 3 2 4
Total Income 99 119 111 132 117 117 141 165 152 176
Total Expenditure 93 109 96 120 105 102 126 148 132 148
Operating Profit 6 10 14 12 12 15 15 17 20 28
Interest 0 0 0 1 0 0 0 0 0 0
Depreciation 4 3 3 3 2 2 2 2 2 2
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 2 7 11 9 10 13 12 15 18 25
Provision for Tax 1 2 2 1 2 3 3 4 4 6
Profit After Tax 1 6 9 7 7 10 9 12 14 19
Adjustments 0 -0 0 0 0 -0 -0 0 -0 0
Profit After Adjustments 1 6 9 7 7 10 9 12 14 19
Adjusted Earnings Per Share 0.2 1.1 1.7 1.5 1.5 2 1.9 2.3 2.8 3.8

Anuh Pharma Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 243 266 284 326 206 238 321 307 432 487 527 622
Other Income 2 4 5 4 8 7 5 4 11 5 6 11
Total Income 245 271 289 330 214 245 325 311 442 492 534 634
Total Expenditure 225 242 253 289 183 220 291 284 387 439 476 554
Operating Profit 20 28 36 41 30 26 35 27 56 53 58 80
Interest 1 1 1 1 1 0 1 1 2 2 1 0
Depreciation 2 2 3 2 2 2 2 7 15 12 10 8
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 18 25 32 38 28 23 32 19 39 39 47 70
Provision for Tax 5 8 10 12 8 7 9 5 10 9 11 17
Profit After Tax 13 18 22 26 20 17 23 14 28 31 36 54
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 13 18 22 26 20 17 23 14 28 31 36 54
Adjusted Earnings Per Share 2.5 3.5 4.4 5.1 4 3.3 4.7 2.9 5.7 6.1 7.2 10.8

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 8% 20% 17% 8%
Operating Profit CAGR 9% 29% 17% 11%
PAT CAGR 16% 37% 16% 11%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 157% 11% 29% 25%
ROE Average 16% 16% 14% 17%
ROCE Average 21% 20% 18% 23%

Anuh Pharma Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 76 86 101 119 141 150 165 162 191 214 241
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 1 -0 -0 -0 -0 -0 1 3 2 2
Total Current Liabilities 60 77 67 72 47 59 75 163 139 131 161
Total Liabilities 136 163 168 191 187 208 239 326 333 347 404
Fixed Assets 10 12 9 18 17 17 21 84 71 61 53
Other Non-Current Assets 9 10 15 22 32 37 66 19 23 27 44
Total Current Assets 117 142 144 151 138 154 152 223 238 259 308
Total Assets 136 163 168 191 187 208 239 326 333 347 404

Anuh Pharma Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0 2 1 3 5 4 7 2 2 4
Cash Flow from Operating Activities 2 15 19 16 26 2 7 49 -19 29 54
Cash Flow from Investing Activities 4 -5 -12 -5 -20 2 3 -77 52 -8 -43
Cash Flow from Financing Activities -6 -8 -8 -9 -4 -5 -7 22 -33 -19 -12
Net Cash Inflow / Outflow -0 2 -1 2 2 -1 3 -5 0 2 -2
Closing Cash & Cash Equivalent 0 2 1 3 5 4 7 2 2 4 2

Anuh Pharma Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 2.5 3.51 4.39 5.15 4 3.3 4.66 2.85 5.67 6.1 7.22
CEPS(Rs) 2.83 3.86 5.04 5.6 4.39 3.66 4.99 4.26 8.68 8.49 9.16
DPS(Rs) 6 7.75 7 2.5 2.5 2.75 2.75 2.75 1.5 1.75 2
Book NAV/Share(Rs) 15.09 17.14 20.13 23.8 28.05 29.86 32.85 32.37 38.04 42.66 48.14
Core EBITDA Margin(%) 6.96 8.52 10.3 10.99 10.46 7.53 9.3 7.31 10.25 9.67 9.78
EBIT Margin(%) 7.17 9.36 10.89 11.35 13.05 9.81 10.24 6.42 9.22 8.29 9.1
Pre Tax Margin(%) 6.78 8.94 10.57 11.1 12.72 9.63 10.06 6.03 8.75 7.97 8.96
PAT Margin (%) 4.81 6.17 7.3 7.55 9.24 6.79 7.25 4.5 6.46 6.22 6.83
Cash Profit Margin (%) 5.45 6.78 8.38 8.21 10.15 7.54 7.77 6.71 9.88 8.66 8.66
ROA(%) 9.83 11.75 13.29 14.37 10.58 8.35 10.44 5.06 8.63 8.99 9.63
ROE(%) 17.31 21.78 23.55 23.44 15.43 11.38 14.87 8.75 16.12 15.11 15.9
ROCE(%) 25.5 32.94 35.13 34.91 21.61 16.31 20.56 10.87 19.75 19.33 21.05
Receivable days 65.47 82.72 86.54 76.28 110.46 95.73 82.39 89.32 77.87 90.17 105.71
Inventory Days 25.39 27.54 21.65 21.42 45.01 46.32 42.34 59.91 59.23 59.98 52.54
Payable days 69.68 91.64 89.58 74.14 115.42 95.69 83.81 130.55 125.15 117.42 125.45
PER(x) 8.16 6.6 18.54 19.15 25.16 23.75 14.5 20.41 15.91 14.09 11.03
Price/Book(x) 1.35 1.35 4.04 4.14 3.59 2.62 2.06 1.8 2.37 2.01 1.65
Dividend Yield(%) 4.9 5.58 1.43 1.27 1.24 1.76 2.03 2.36 1.66 2.04 2.51
EV/Net Sales(x) 0.37 0.38 1.39 1.48 2.42 1.62 1.03 1.09 1.03 0.86 0.74
EV/Core EBITDA(x) 4.39 3.54 10.91 11.76 16.45 15.05 9.57 12.17 8.01 7.94 6.77
Net Sales Growth(%) 7.53 9.78 6.49 14.99 -36.81 15.49 34.68 -4.27 40.72 12.66 8.39
EBIT Growth(%) -2.9 42.73 22.92 18.28 -27.05 -15.68 38.26 -38.14 98.8 0.3 18.46
PAT Growth(%) -2.42 40.33 25.02 17.34 -22.3 -17.65 41.51 -38.78 98.78 7.47 18.38
EPS Growth(%) -2.42 40.33 25.02 17.34 -22.3 -17.65 41.51 -38.78 98.78 7.47 18.38
Debt/Equity(x) 0.01 0 0 0.02 0 0.02 0.03 0.27 0.07 0.01 0
Current Ratio(x) 1.94 1.84 2.15 2.08 2.91 2.63 2.03 1.37 1.7 1.98 1.91
Quick Ratio(x) 1.55 1.59 1.9 1.76 2.28 2.09 1.46 0.99 1.12 1.37 1.46
Interest Cover(x) 18.44 22.02 34.69 44.87 39.3 52.91 55.16 16.23 19.99 25.76 64.61
Total Debt/Mcap(x) 0.01 0 0 0 0 0.01 0.01 0.15 0.03 0.01 0

Anuh Pharma Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 70.45 70.44 70.59 70.59 70.59 70.59 70.59 70.59 69.94 69.92
FII 0 0 0 0 0 0 0 0 0 0.03
DII 0 0 0 0 0 0 0 0 0 0.11
Public 29.55 29.56 29.41 29.41 29.41 29.41 29.4 29.41 30.06 29.95
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company is almost debt free.

Cons

  • Debtor days have increased from 117.42 to 125.45days.
  • Stock is trading at 4.1 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Anuh Pharma News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!